CORV News and Press, Correvio Pharma Corp. From 11/07/19

Correvio to Report Third Quarter 2019 Financial Results Canada NewsWire VANCOUVER, Nov. 7, 2019 NASDAQ: CORV  TSX: CORV Conference Call Scheduled for Thursday, November 14, 2019 at 8:30 a.m. Eastern ( 5:30 a.m. Pacific) VANCOUVER , Nov. 7, 2019 /CNW/ - ...

Correvio Announces FDA Advisory Committee Meeting to Review Brinavess™ for Recent Onset Atrial Fibrillation Canada NewsWire VANCOUVER, Nov. 4, 2019 NASDAQ: CORV   TSX: CORV VANCOUVER , Nov. 4, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CO...

NASDAQ: CORV   TSX: CORV VANCOUVER , Sept. 27, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Mark H.N. Corrigan , MD, Chief Executive Officer of Corre...

The following slide deck was published by Correvio Pharma Corp. in conjunction with this Read more ...

Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application Canada NewsWire VANCOUVER, Sept. 12, 2019 NASDAQ: CORV   TSX: CORV VANCOUVER , Sept. 12, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharm...

NASDAQ: CORV  TSX: CORV VANCOUVER , Sept. 4, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Justin Renz , President and Chief Financial Officer of Corre...

Correvio Pharma (NASDAQ: CORV ) initiated with Overweight rating and $6 (193% upside) price target at Cantor Fitzgerald. More news on: Correvio Pharma Corp., InMode Ltd., MeiraGTx Holdings plc, Healthcare stocks news, Stocks on the move, , Read more ...

Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress Canada NewsWire VANCOUVER, Sept. 3, 2019 Safety Outcomes of Interest Observed in Less Than 1% Cases; Zero Deaths Reported Greater Than 70% of Atrial Fibr...

Noteworthy events during the week of August 25 - 31 for healthcare investors. More news on: Daiichi Sankyo Company, Limited, Intellipharmaceutics International Inc., Nektar Therapeutics, Healthcare stocks news, , Read more ...

Correvio Pharma Corp. (CORV) Q2 2019 Earnings Conference Call August 14, 2019 08:30 AM ET Company Participants Justin Renz - CFO Mark Corrigan - CEO David Dean - Chief Business Development Officer Conference Call Participants David Martin - Bloom Burton Swayampakula Ramak...